EWL.F
Edwards Lifesciences Corporation
FrankfurtEUREQUITY
Healthcare
DELAYED
Last price
77.98
▲ 1.22 (1.59%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
76.46
Prev close
76.76
Day high
77.98
Day low
76.46
Volume
25
Market cap
$44.95B
P/E (TTM)
54.15
52W range
59.49 – 83.52
Day trading desk
Gap from prior close
-0.39%
Prior close 76.76
VWAP
77.32
+0.85% from price
Relative volume
0.30×
Quiet session
Session range
1.99%
76.46 – 77.98
Position in range
100%
Near session high
ATR (14D)
1.38
1.77% of price
Prior day high
77.08
PDH
Prior day low
75.92
PDL
Bid / ask spread
—
Quote not published
Session volume
25
Avg 84
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-0.43%
+0.7%
1M
+7.14%
+3.8%
3M
+4.95%
+2.5%
6M
+11.27%
-0.7%
YTD
+6.21%
-5.8%
1Y
+12.25%
-8.0%
3Y
+8.43%
-66.7%
5Y
-23.55%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on EWL.F open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
1.12M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 11, 26 | LIPPIS DANIEL J Officer |
SELL | 619 | $56.97K | Direct |
| Aug 11, 26 | LIPPIS DANIEL J Officer |
CONVERSION | 619 | $44.99K | Direct |
| Jul 30, 26 | MARKOWITZ WAYNE Officer |
SELL | 146 | $12.59K | Direct |
| Jul 28, 26 | MARKOWITZ WAYNE Officer |
SELL | 9.63K | $818.96K | Direct |
| Jul 28, 26 | MARKOWITZ WAYNE Officer |
CONVERSION | 9.63K | $712.66K | Direct |
| Jul 27, 26 | ZOVIGHIAN BERNARD J Chief Executive Officer |
STOCK | 319 | $0 | Direct |
| Jul 27, 26 | ZOVIGHIAN BERNARD J Chief Executive Officer |
SELL | 2.92K | $245.13K | Indirect |
| Jul 10, 26 | LIPPIS DANIEL J Officer |
SELL | 619 | $56.76K | Direct |
| Jul 10, 26 | LIPPIS DANIEL J Officer |
CONVERSION | 619 | $44.99K | Direct |
| Jul 9, 26 | MISTRAS THEODORA Chief Financial Officer |
STOCK | 99.92K | $0 | Direct |
| Jun 30, 26 | LIPPIS DANIEL J Officer |
SELL | 619 | $56.58K | Direct |
| Jun 30, 26 | LIPPIS DANIEL J Officer |
CONVERSION | 619 | $44.99K | Direct |
| Jun 17, 26 | ZOVIGHIAN BERNARD J Chief Executive Officer |
SELL | 523 | $45.98K | Indirect |
| May 29, 26 | DAHL ANDREW M Officer |
SELL | 567 | $48.85K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BOBO DONALD E JR |
Officer | — | Sale |
CHOPRA DAVEEN |
Officer | 44.32K | Sale |
GALLAHUE KIERAN T. |
Director | 83.97K | Stock Award(Grant) |
LORANGER STEVEN R |
Director | 84.37K | Stock Award(Grant) |
MISTRAS THEODORA |
Chief Financial Officer | 99.92K | Stock Award(Grant) |
SZYMAN CATHERINE M |
Officer | 81.29K | Stock Award(Grant) |
ULLEM SCOTT B |
Chief Financial Officer | 313.06K | Conversion of Exercise of derivative security |
VALERIANI NICHOLAS J |
Director | 84.42K | Stock Award(Grant) |
WOOD LARRY L |
Officer | 207.05K | Sale |
ZOVIGHIAN BERNARD J |
Chief Executive Officer | 111.49K | Stock Gift |
Fundamentals
Market cap$44.95B
Enterprise value$40.80B
Revenue (TTM)$6.51B
Gross profit$5.07B
EBITDA$2.00B
Net income$979.90M
EPS (TTM)$1.44
Free cash flow$1.23B
Total cash$4.25B
Total debt$704.40M
Book value / share$15.92
Shares outstanding576.40M
Float574.49M
Short % of float—
Dividend yield—
Beta (5Y)0.85
Valuation & profitability ratios
Trailing P/E54.15
Forward P/E30.11
PEG ratio2.16
Price / sales—
Price / book4.90
EV / revenue6.27
EV / EBITDA20.43
Gross margin77.84%
Operating margin29.84%
Profit margin15.43%
Return on equity9.18%
Return on assets8.37%
Debt / equity6.57
Current ratio4.52
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $6.07B | $5.44B | $5.01B | $4.46B | +11.5% |
| Operating revenue | $6.07B | $5.44B | $5.01B | $4.46B | +11.5% |
| Cost of revenue | $1.33B | $1.12B | $978.40M | $723.70M | +19.4% |
| Gross profit | $4.73B | $4.32B | $4.03B | $3.74B | +9.5% |
| Research & development | $1.08B | $1.05B | $962.90M | $843.60M | +2.5% |
| Selling, general & admin | $2.09B | $1.79B | $1.58B | $1.36B | +16.5% |
| Total operating expense | $3.10B | $2.84B | $2.55B | $2.20B | +9.0% |
| Operating income | $1.64B | $1.48B | $1.49B | $1.54B | +10.5% |
| Net interest income | $148.40M | $100.50M | $49.60M | $16.30M | +47.7% |
| Pre-tax income | $1.27B | $1.55B | $1.37B | $1.52B | -17.8% |
| Tax provision | $216.90M | $152.10M | $152.40M | $195.50M | +42.6% |
| Net income | $1.07B | $4.17B | $1.40B | $1.52B | -74.3% |
| Net income to common | $1.07B | $4.17B | $1.40B | $1.52B | -74.3% |
| Basic EPS | 1.84 | 6.98 | 2.31 | 2.46 | -73.6% |
| Diluted EPS | 1.83 | 6.97 | 2.30 | 2.44 | -73.7% |
| EBIT | $1.29B | $1.57B | $1.39B | $1.54B | -17.5% |
| EBITDA | $1.45B | $1.72B | $1.53B | $1.68B | -15.9% |
| Basic shares | 584.80M | 597.70M | 606.70M | 619.00M | -2.2% |
| Diluted shares | 585.80M | 599.30M | 609.40M | 624.20M | -2.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $2.94B | $3.05B | $1.13B | $769.00M | -3.5% |
| Cash & short-term investments | $4.23B | $3.98B | $1.63B | $1.22B | +6.3% |
| Accounts receivable | $659.60M | $609.10M | $771.50M | $643.00M | +8.3% |
| Inventory | $1.13B | $1.09B | $903.50M | $875.50M | +3.6% |
| Total current assets | $6.74B | $6.29B | $4.04B | $3.10B | +7.2% |
| Property, plant & equipment | $1.91B | $1.78B | $1.68B | $1.73B | +7.3% |
| Goodwill & intangibles | $2.90B | $2.95B | $1.54B | $1.45B | -1.9% |
| Total assets | $13.70B | $13.06B | $9.36B | $8.29B | +4.9% |
| Total current liabilities | $1.81B | $1.51B | $1.20B | $1.02B | +20.5% |
| Long-term debt | $598.30M | $597.70M | $597.00M | $596.30M | +0.1% |
| Total debt | $705.40M | $700.00M | $685.10M | $691.30M | +0.8% |
| Total liabilities | $3.36B | $2.99B | $2.64B | $2.49B | +12.3% |
| Retained earnings | $14.24B | $13.17B | $8.99B | $7.59B | +8.2% |
| Shareholder equity | $10.34B | $10.00B | $6.65B | $5.81B | +3.4% |
| Working capital | $4.93B | $4.78B | $2.84B | $2.07B | +3.0% |
| Net tangible assets | $7.44B | $7.05B | $5.11B | $4.36B | +5.6% |
| Shares issued | 658.70M | 654.80M | 650.50M | 646.30M | +0.6% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $1.07B | $4.17B | $1.40B | $1.52B | -74.4% |
| Depreciation & amortisation | $156.60M | $155.20M | $144.90M | $139.60M | +0.9% |
| Stock-based compensation | $158.10M | $162.30M | $139.40M | $126.80M | -2.6% |
| Change in working capital | $154.60M | -$259.30M | -$526.30M | -$421.40M | +159.6% |
| Operating cash flow | $1.60B | $542.30M | $895.80M | $1.22B | +194.2% |
| Capital expenditure | -$260.20M | -$282.40M | -$266.30M | -$264.80M | +7.9% |
| Investing cash flow | -$712.90M | $2.31B | $173.80M | $252.30M | -130.8% |
| Share buybacks | -$893.40M | -$1.16B | -$879.60M | -$1.73B | +22.9% |
| Financing cash flow | -$956.80M | -$983.00M | -$711.00M | -$1.58B | +2.7% |
| Free cash flow | $1.33B | $259.90M | $629.50M | $953.40M | +413.7% |
| End cash position | $2.94B | $3.06B | $1.15B | $772.60M | -3.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $1.74B | $1.65B | $1.57B | $1.55B | $1.53B | — | +5.6% |
| Operating revenue | $1.74B | $1.65B | $1.57B | $1.55B | $1.53B | — | +5.6% |
| Cost of revenue | $392.40M | $362.60M | $343.00M | $345.20M | $344.40M | — | +8.2% |
| Gross profit | $1.35B | $1.29B | $1.23B | $1.21B | $1.19B | — | +4.9% |
| Research & development | $278.90M | $263.30M | $267.70M | $280.70M | $276.20M | — | +5.9% |
| Selling, general & admin | $561.20M | $522.20M | $602.90M | $514.60M | $502.00M | — | +7.5% |
| Total operating expense | $829.10M | $771.30M | $856.30M | $782.80M | $756.90M | — | +7.5% |
| Operating income | $519.50M | $514.70M | $370.30M | $425.10M | $430.90M | — | +0.9% |
| Net interest income | $30.00M | $33.50M | $35.90M | $38.60M | $37.40M | — | -10.4% |
| Pre-tax income | $519.80M | — | — | — | — | — | — |
| Tax provision | $278.40M | $78.30M | $26.20M | $56.10M | $64.30M | — | +255.6% |
| Net income | $241.90M | $380.70M | $91.20M | $291.10M | $333.20M | — | -36.5% |
| Net income to common | $241.90M | $380.70M | $91.20M | $291.10M | $333.20M | — | -36.5% |
| Basic EPS | 0.42 | 0.66 | 0.16 | — | 0.57 | 0.61 | -36.4% |
| Diluted EPS | 0.42 | 0.66 | 0.16 | — | 0.56 | 0.61 | -36.4% |
| EBIT | $519.50M | $514.70M | $27.40M | $425.10M | $430.90M | — | +0.9% |
| EBITDA | $562.20M | $555.60M | $70.10M | $464.30M | $469.00M | — | +1.2% |
| Basic shares | 576.40M | 579.20M | 580.40M | — | 587.00M | 586.90M | -0.5% |
| Diluted shares | 577.60M | 580.70M | 581.80M | — | 587.90M | 587.80M | -0.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $2.91B | $2.45B | $2.94B | $2.69B | $3.27B | +18.9% |
| Cash & short-term investments | $4.25B | $3.67B | $4.23B | $3.84B | $4.06B | +15.8% |
| Accounts receivable | $770.40M | $775.70M | $659.60M | $693.30M | $697.00M | -0.7% |
| Inventory | $1.13B | $1.12B | $1.13B | $1.14B | $1.14B | +1.1% |
| Total current assets | $6.82B | $6.23B | $6.74B | $6.36B | $6.58B | +9.5% |
| Property, plant & equipment | $1.94B | $1.92B | $1.91B | $1.84B | $1.83B | +1.0% |
| Goodwill & intangibles | $3.33B | $3.05B | $2.90B | $2.90B | $2.95B | +9.4% |
| Total assets | $13.87B | $13.32B | $13.70B | $13.27B | $13.49B | +4.1% |
| Total current liabilities | $1.51B | $1.41B | $1.81B | $1.59B | $1.40B | +7.0% |
| Long-term debt | $598.70M | $598.50M | $598.30M | $598.20M | $598.00M | +0.0% |
| Total debt | $704.40M | $702.90M | $705.40M | $700.30M | $702.60M | +0.2% |
| Total liabilities | $3.14B | $2.99B | $3.36B | $3.07B | $2.88B | +5.0% |
| Retained earnings | $14.86B | $14.62B | $14.24B | $14.15B | $13.86B | +1.7% |
| Shareholder equity | $10.62B | $10.33B | $10.34B | $10.21B | $10.55B | +2.8% |
| Working capital | $5.31B | $4.82B | $4.93B | $4.77B | $5.17B | +10.2% |
| Net tangible assets | $7.28B | $7.28B | $7.44B | $7.31B | $7.60B | +0.1% |
| Shares issued | 576.60M | 660.00M | 658.70M | 658.20M | 657.60M | -12.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $241.40M | $380.70M | $91.20M | $290.30M | $331.50M | -36.6% |
| Depreciation & amortisation | $42.70M | $40.90M | $42.70M | $39.20M | $38.10M | +4.4% |
| Stock-based compensation | $42.20M | $45.40M | $39.20M | $41.20M | $37.50M | -7.0% |
| Change in working capital | $131.90M | -$501.50M | $254.30M | $192.70M | -$141.70M | +126.3% |
| Operating cash flow | $651.90M | $43.80M | $450.90M | $573.70M | $290.20M | +1,388.4% |
| Capital expenditure | -$66.90M | -$64.90M | -$97.40M | -$57.50M | -$49.30M | -3.1% |
| Investing cash flow | -$193.20M | -$92.80M | -$198.30M | -$427.80M | -$172.10M | -108.2% |
| Share buybacks | -$153.30M | -$421.80M | -$40.60M | -$588.70M | -$5.50M | +63.7% |
| Financing cash flow | -$300.00K | -$451.20M | -$11.40M | -$740.10M | $52.70M | +99.9% |
| Free cash flow | $585.00M | -$21.10M | $353.50M | $516.20M | $240.90M | +2,872.5% |
| End cash position | $2.91B | $2.45B | $2.94B | $2.69B | $3.29B | +18.9% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $1.68B | +7.9% |
| Next quarter | — | — | $1.70B | +8.4% |
| Current year | — | — | $6.76B | +11.4% |
| Next year | — | — | $7.43B | +9.9% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders0.19%
Held by institutions97.11%
Institutions holding1.92K
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
78.89
-1.16% from price
SMA 20
77.61
+0.47% from price
SMA 50
77.67
+0.40% from price
SMA 100
74.31
+4.93% from price
SMA 200
72.75
+7.18% from price
EMA 12
78.05
-0.09% from price
EMA 26
77.65
+0.43% from price
EMA 50
76.88
+1.43% from price
RSI (14)
51.6
Neutral
MACD (12,26,9)
0.40
Hist -0.12
ATR (14)
1.38
1.77% of price
Realised vol 30D
23.5%
Annualised
Bollinger upper
81.71
20, 2σ
Bollinger lower
73.51
20, 2σ
50 / 200 cross
Golden
77.67 vs 72.75
Trend bias
Above 200
+7.18%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.17
Less volatile than market
Correlation to SPY
0.08
Largely independent
Realised vol 30D
23.5%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-15.0%
Peak to trough
Max drawdown 5Y
-53.1%
Peak to trough
ATR 14
1.38
1.77% of price
Beta (reported)
0.85
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 25, 26 | Leerink Partners | UPGRADE | Market Perform | Outperform |
| Jul 24, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Jul 24, 26 | Piper Sandler | MAINTAINED | Overweight | Overweight |
| Jul 16, 26 | Truist Securities | MAINTAINED | Hold | Hold |
| Jul 15, 26 | Mizuho | MAINTAINED | Outperform | Outperform |
| Jul 13, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Jul 8, 26 | Citigroup | MAINTAINED | Buy | Buy |
| Jul 6, 26 | Evercore ISI Group | MAINTAINED | Outperform | Outperform |
| Jun 30, 26 | BTIG | MAINTAINED | Buy | Buy |
| Jun 16, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Jun 2, 26 | TD Cowen | MAINTAINED | Buy | Buy |
| Apr 27, 26 | Barclays | MAINTAINED | Overweight | Overweight |
Dividends & splits
Forward rate—
Forward yield—
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split3:1
Split dateJun 1, 2020
Headlines
Exxon Drops as Oil Retreats From $94
GuruFocus.com · 5m ago
Johnson & Johnson Rises 1.3% as Investors Seek Stability
GuruFocus.com · 6m ago
Eli Lilly Slips as Its $1.1 Trillion Valuation Cools
GuruFocus.com · 7m ago
Nvidia's valuation looks surprisingly cheap heading into earnings. Could it be an issue for the stock?
Yahoo Finance · 7m ago
U.S. Stocks Mixed With Nasdaq Slipping on Weakness in Tech Sector
The Wall Street Journal · 8m ago
Current Standardizes Its $600M Firm Network on a Single Platform
PR Newswire · 8m ago
Bessent's Iranian sanction target these 5 key sectors
Yahoo Finance Video · 8m ago
Dollar higher after Iran sanctions, loonie drops after US announces tariff increases
Reuters · 9m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.